Since 1996 WHN is the second oldest medical website on the net, second only to the American Medical Association, servicing over 35,000 physicians and scientists worldwide.

Non-Profit Trusted Source of Non-Commercial Health Information

WHN Forum background globe
AI Assistant
Forums
Psychedelics
Psychedelic Medicat...
Psyence BioMed Expa...
 
Notifications
Clear all

Psyence BioMed Expands Australian Clinical Network To 5 Sites For Psilocybin Phase IIb Trial

 
Psychedelic Medication
Last Post by Anonymous 1 month ago
1 Posts
1 Users
0 Reactions
33 Views
Solved
RSS
 Dr. Fisher
(@Dr. Fisher)
Joined: 1 month ago
Posts: 18
Topic starter
Translate â–¼
English
Spanish
French
German
Italian
Portuguese
Russian
Chinese
Japanese
Korean
Arabic
Hindi
Dutch
Polish
Turkish
Vietnamese
Thai
Swedish
Danish
Finnish
Norwegian
Czech
Hungarian
Romanian
Greek
Hebrew
Indonesian
Malay
Ukrainian
Bulgarian
Croatian
Slovak
Slovenian
Serbian
Lithuanian
Latvian
Estonian
10/04/2026 5:01 am  

syence Biomedical Ltd. (NASDAQ:PBM) (Psyence BioMed or the Company), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine ...

https://www.sahmcapital.com/news/content/psyence-biomed-expands-australian-clinical-network-to-5-sites-for-psilocybin-phase-iib-trial-2026-04-08



   
Quote
Topic Tags
psilocybin ibogaine psyence biomed biomed expands expands australian

Leave a reply

Author Name

Author Email

Title *

Maximum allowed file size is 400MB

 
Preview 0 Revisions Saved
Forum Jump:
  Previous Topic
Next Topic  
Related Topics
Topic Tags:  psilocybin (163) , ibogaine (29) , psyence biomed (2) , biomed expands (1) , expands australian (2) ,